Changes in health-related quality of life after ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins
| Autor: | Andrew W. Bradbury, Donald J. Adam, Gareth Bate, K.A.L. Darvall, S.H. Silverman, R.C. Sam |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors medicine.medical_treatment Compression stockings Varicose Veins Young Adult Quality of life Surveys and Questionnaires Sclerotherapy Varicose veins Humans Medicine Saphenous Vein Ultrasonography Interventional Aged Aged 80 and over Varix business.industry Vascular disease Sclerosing Solutions Middle Aged medicine.disease humanities Surgery Treatment Outcome Quality of Life Female medicine.symptom business Varices Cardiology and Cardiovascular Medicine Stockings Compression |
| Zdroj: | Journal of Vascular Surgery. 51(4):913-920 |
| ISSN: | 0741-5214 |
| DOI: | 10.1016/j.jvs.2009.11.045 |
| Popis: | Health-related quality of life (HRQOL) improves after superficial venous surgery for varicose veins, but the effect of ultrasound-guided foam sclerotherapy on HRQOL is unknown. The aim of this study was to determine changes in HRQOL after ultrasound-guided foam sclerotherapy for varicose veins.Consecutive patients undergoing ultrasound-guided foam sclerotherapy for varicose veins were sent the Short Form 12 (SF-12) questionnaire, a generic measure of HRQOL, and the Aberdeen Varicose Vein Symptom Score (AVSS) questionnaire, a disease-specific measure of HRQOL, 1 week before treatment and 1, 6, and 12 months after treatment.The study enrolled 296 patients (34% male; 395 treated legs) with a median age of 57 years (range, 22-89 years). Of these, 24% had had previous superficial venous surgery, and 66% were CEAP C(2-3) (uncomplicated varicose veins). Questionnaire completion rates were 82%, 73%, and 69% at 1, 6, and 12 months after treatment. The median Physical Component Summary score of the SF-12 (higher score indicates better HRQOL) improved from 47.6 pretreatment to 49.4 at 1 month (P.008, Wilcoxon signed rank test), to 51.9 at 6 months (P.0005), and to 52.9 at 12 months (P.0005). The median AVSS (lower score indicates better HRQOL) improved from 19.0 pretreatment to 16.5 at 1 month (P.0005), to 8.7 at 6 months (P.0005), and to 8.6 at 12 months (P.0005).Ultrasound-guided foam sclerotherapy for great and small saphenous varicose veins leads to significant improvements in generic and disease-specific HRQOL for at least 12 months after treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|